CIK 0001527728 · Non-accelerated filer<br>Smaller reporting company
Lunai Bioworks Inc.
Sign in to watch- Ticker
- LNAI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452259340
- Phone
- 45 39179840
- Business address
- CENTURY CITY MEDICAL PLAZA, 2080 CENTURY CITY EAST, SUITE 906 LOS ANGELES, CA, 90067
- Former names
- RENOVARO INC., RENOVARO BIOSCIENCES INC., Enochian Biosciences Inc, DanDrit Biotech USA, Inc., Putnam Hills Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-10 | William Anderson Wittekind 10% owner | Other disposition | −350,000 | 3,353,878 | ||
| 2025-01-21 | van Tilburg Maurice Director | Grant or award | +250,000 | 250,000 | ||
| 2025-01-21 | van Tilburg Maurice Director | Grant or award · Option to purchase shares of common stock | +1,000,000 | 1,000,000 | ||
| 2025-01-21 | Fuentes Nathen Chief Financial Officer | Grant or award · Option to purchase shares of common stock | +250,000 | 250,000 | ||
| 2024-11-04 | Collins Mark Anthony Director | Grant or award · Option to purchase shares of common stock | +120,968 | 120,968 | ||
| 2024-11-04 | Calder Douglas W Director | Grant or award · Option to purchase shares of common stock | +120,968 | 120,968 | ||
| 2024-11-04 | Tarsh Simon Interim CFO | Grant or award · Option to purchase shares of common stock | +58,500 | 58,500 | ||
| 2024-11-04 | MCNULTY JAMES A Director | Grant or award · Option to purchase shares of common stock | +120,968 | 120,968 | ||
| 2024-10-14 | Weinstein David Hershel Chief Executive Officer | Grant or award | +250,000 | 250,000 | ||
| 2024-10-14 | Weinstein David Hershel Chief Executive Officer | Grant or award · Option to purchase shares of common stock | +1,600,000 | 1,600,000 | ||
| 2024-08-23 | Miller Avram Director | Returned to the company | −833,333 | 166,667 | ||
| 2024-08-23 | Miller Avram Director | Grant or award · Option to Purchase Shares of Common Stock | +978,261 | 978,261 | ||
| 2024-08-12 | Brink Karen Director | Other acquisition | +2,000,000 | 25,372,969 | ||
| 2024-08-12 | Brink Karen Director | Other disposition | −2,000,000 | 23,372,969 | ||
| 2024-07-29 | William Anderson Wittekind 10% owner | Sale | −1,114 | $1.30 | $1K | 840,319 |
| 2024-07-17 | William Anderson Wittekind 10% owner | Sale | −16,362 | $1.46 | $24K | 841,433 |
| 2024-07-15 | William Anderson Wittekind 10% owner | Sale | −21,954 | $1.41 | $31K | 875,795 |
| 2024-07-11 | William Anderson Wittekind 10% owner | Sale | −14,896 | $1.51 | $22K | 897,749 |
| 2024-07-10 | William Anderson Wittekind 10% owner | Sale | −75,000 | $1.51 | $113K | 894,645 |
| 2024-07-09 | William Anderson Wittekind 10% owner | Sale | −4,630 | $1.53 | $7K | 969,645 |
Page 1 of 10 · 198 trades